BAP1 and kidney cancer: Germline BAP1 mutation underpins a cancer predisposition syndrome [18, 25, 26, 28–30] and BAP1 protein expression is reportedly lost in around 50% of NSCLC, colon carcinoma, uveal melanoma and kidney cancers [31–37].